Literature DB >> 1684850

BstNI/NciI polymorphism of the human p53 gene (TP53).

P M Chumakov1, J R Jenkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1684850      PMCID： PMC329357          DOI： 10.1093/nar/19.24.6969-a

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  1 in total

1.  Human p53 gene localized to short arm of chromosome 17.

Authors:  C Miller; T Mohandas; D Wolf; M Prokocimer; V Rotter; H P Koeffler
Journal:  Nature       Date:  1986 Feb 27-Mar 5       Impact factor: 49.962
  1 in total
  10 in total

1.  Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.

Authors:  Xiang-Hua Ye; Zhi-Bin Bu; Jie Feng; Ling Peng; Xin-Biao Liao; Xin-Li Zhu; Xiao-Li Sun; Hao-Gang Yu; Dan-Fang Yan; Sen-Xiang Yan
Journal:  Mol Biol Rep       Date:  2013-11-23       Impact factor: 2.316

Review 2.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing.

Authors:  A C Syvänen; A Sajantila; M Lukka
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

4.  Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma.

Authors:  Venkat R Katkoori; Xu Jia; Chandrakumar Shanmugam; Wen Wan; Sreelatha Meleth; Harvey Bumpers; William E Grizzle; Upender Manne
Journal:  Clin Cancer Res       Date:  2009-04-01       Impact factor: 12.531

5.  Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis.

Authors:  A Weston; J H Godbold
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

Review 6.  Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment.

Authors:  Roman Hrstka; Philip J Coates; Borivoj Vojtesek
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

7.  Analysis of R213R and 13494 g-->a polymorphisms of the p53 gene in individuals with esophagitis, intestinal metaplasia of the cardia and Barrett's Esophagus compared with a control group.

Authors:  Diogo André Pilger; Patrícia Luciana da Costa Lopez; Fábio Segal; Sandra Leistner-Segal
Journal:  Genomic Med       Date:  2007-05-25

8.  p53 mutations and overexpression in locally advanced breast cancers.

Authors:  A Faille; P De Cremoux; J M Extra; G Linares; M Espie; E Bourstyn; A De Rocquancourt; S Giacchetti; M Marty; F Calvo
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

9.  High frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence population.

Authors:  A Hartmann; H Blaszyk; S Saitoh; K Tsushima; Y Tamura; J M Cunningham; R M McGovern; J J Schroeder; S S Sommer; J S Kovach
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

10.  Functional consequence of the p53 codon 72 polymorphism in colorectal cancer.

Authors:  Venkat R Katkoori; Upender Manne; Lakshmi S Chaturvedi; Marc D Basson; Pam Haan; Daniel Coffey; Harvey L Bumpers
Journal:  Oncotarget       Date:  2017-08-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.